What might the German election mean for markets?
With the top two positions at the Federal Reserve soon to be open, Russ discusses how the easy money era goes back a long way.
Rick Rieder explains the economic implications of “the Amazon effect.”
Russ explores why both risky assets and traditional safe havens have performed well this year, and whether that can continue.
Value stocks have largely sat out the broader market rallies this year. Russ explains why, and what could spark a return to investor favor.
We believe biotech's long-term historical drivers, demographics and mergers and acquisitions (M&A) activity to secure patent protected drugs, may outlast near-term political headwinds and should lead investors to consider bio-pharma from a longer-term perspective. Biotech valuations also currently appear attractive relative to the broader market and look less crowded than other growth sectors. Over the short term we see potential opportunities in select individual biotech and pharma names.
Russ discusses the trend behind the surprising gold rally this year, and why the political drama in D.C. means it may continue.
We see three factors that potentially support Japanese equities going forward: 1. Improving earnings outlook amid a strengthening domestic economy and synchronized global expansion. 2. Currently attractive equity valuations compared to developed market peers. 3. Continued monetary stimulus from the Bank of Japan and a potentially stable yen.
Whatever happened to the increase in interest rates that was supposed to occur? Russ explains.
Rick explains what many interpreters of inflation data are missing.